Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1996-7-9
pubmed:abstractText
Shionogi Carcinoma 115 (SC 115) cells are a cloned cell line derived from androgen-dependent mouse mammary tumor. They can grow in serum-free culture if a physiological level of androgen is present in the medium, but can not proliferate in culture without testosterone. In the present study, the mechanism of cell death in SC 115 cells after androgen withdrawal was examined. Based upon the temporal sequence of DNA fragmentation, morphologic changes and loss of cell viability, androgen withdrawal induces programmed cell death (apoptosis) of SC 115 cells in serum-free culture. Northern blot analysis was used to identify a series of genes whose expression per cell is enhanced during the recruitment of cells from a nonproliferative (i.e. G0) state into G1 (i.e.,cyclins D1 and C), from G1 into the S phase of the cell cycle (i.e., cdk2), and during the programmed cell death pathway (i.e. testosterone repressed prostatic message-2 (TRPM-2), transforming growth factor-beta1 (TGF-beta1) and glucose regulated 78 kilodalton protein (GRP-78). Expression of TRPM-2, TGF-beta1, GRP-78, and calmodulin genes increases, but that of cyclins C and D1, and cdk2 genes decreases during programmed cell death of SC 115 cells. These results demonstrate that androgen-dependent SC 115 cells undergo programmed cell death induced by androgen withdrawal, and that this death does not require proliferation or progression into G1 of the proliferative cell cycle. SC 115 cells should be a good model for investigating programmed death of hormone-dependent cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0910-5050
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1159-65
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8636004-Androgens, pubmed-meshheading:8636004-Animals, pubmed-meshheading:8636004-Apoptosis, pubmed-meshheading:8636004-Cell Cycle, pubmed-meshheading:8636004-Clusterin, pubmed-meshheading:8636004-Culture Media, Serum-Free, pubmed-meshheading:8636004-Cyclins, pubmed-meshheading:8636004-DNA Damage, pubmed-meshheading:8636004-Female, pubmed-meshheading:8636004-Gene Expression Regulation, Neoplastic, pubmed-meshheading:8636004-Glycoproteins, pubmed-meshheading:8636004-Mammary Neoplasms, Experimental, pubmed-meshheading:8636004-Mice, pubmed-meshheading:8636004-Molecular Chaperones, pubmed-meshheading:8636004-Neoplasm Proteins, pubmed-meshheading:8636004-Neoplasms, Hormone-Dependent, pubmed-meshheading:8636004-Testosterone, pubmed-meshheading:8636004-Transforming Growth Factor beta, pubmed-meshheading:8636004-Tumor Cells, Cultured
pubmed:year
1995
pubmed:articleTitle
Induction of programmed death/apoptosis androgen-dependent mouse mammary tumor cell line (Shionogi Carcinoma 115) by androgen withdrawal.
pubmed:affiliation
Department of Urology, School of Medicine, Chiba University.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't